Trimedyne (OTC BB: TMED) CEO InterviewTrimedyne (OTC BB: TMED) CEO InterviewThis interview has expired. Special deals for our readers Be a more profitable investor: Get an Equifax 3-in-1 Credit Report Now! Why are you still paying too much with Schwab, and and E-trade?? Step up to the #1 discount broker: TradeKing. Invest Smarter! Get 4 Bonus Weeks of Investor’s Business Daily Digital Edition! LifeLock is the only Identity Theft Prevention Solution backed by a one-million dollar guarantee!Click here to get a 10% discount. Get FICO Score Watch Now! Click here to get access to powerful investing tools only available at Investor’s Business Daily. Get a free look at Jim Cramer’s Action Alerts PLUS portfolio. Click here Trimedyne Trimedyne, Inc. is engaged in the development, manufacturing and marketing of 80 and 30 watt Holmium cold pulsed lasers (Lasers) and a variety of disposable and reusable, fiber optic laser energy delivery devices (fibers, needles and tips) for use in an array of medical applications. The lasers, fibers, needles and tips have been cleared for sale by the United States Food and Drug Administration (FDA) for use in orthopedics, urology, ear, nose and throat (ENT) surgery, gynecology, gastrointestinal surgery, general surgery and other medical specialties. The Company’s wholly owned subsidiary Mobile Surgical Technologies, Inc. is engaged in the rental of lasers, along with the services of a trained operator and the provision of applicable fibers, needles or tips, on a fee per case basis to hospitals, surgery centers, group practices and individual physicians in Texas. |
|
Standard Podcast: 
WSR Recommends |
||
| Special Deal for Our Readers (That’s You!) | Jim Cramer: The Clown That Makes You Money | Get Rich with Fibonacci. Learn How to Use Fibonacci Analysis to Trade Better. |
